pegvisomant 20 MG Injection

RxCUI: 403808
RxNorm name: pegvisomant 20 MG Injection
Display name: pegvisomant 20 MG Injection
Full name: pegvisomant 20 MG Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:54

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
021106	Somavert	pegvisomant	351(a)	Rx	2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
SOMAVERT	PEGVISOMANT	Pharmacia & Upjohn Company LLC	3cbb485b-6df1-49ce-8747-592b395b1988	2025-12-18	Warnings, Adverse reactions	Exact identifier rxcui: 403808

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
3cbb485b-6df1-49ce-8747-592b395b1988	pegvisomant 20 MG Injection [PSN] · pegvisomant 20 MG Injection [SCD]	2	13	These highlights do not include all the information needed to use SOMAVERT safely and effectively. See full prescribing information for SOMAVERT. SOMAVERT (pegvisomant) for injection, for subcutaneous use Initial U.S. Approval: 2003	20251218